Singapore markets close in 23 minutes

SAB Biotherapeutics, Inc. (SABS)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
3.8700-0.0600 (-1.53%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-42,194
-42,194
-18,741
-17,145
20,118
Depreciation & amortisation
3,745
3,745
3,292
1,654
548.178
Stock-based compensation
2,424
2,424
2,674
2,315
1,295
Change in working capital
2,326
2,326
-237.575
11,683
-11,954
Accounts receivable
5,557
5,557
2,454
12,559
-17,751
Accounts payable
-2,702
-2,702
-779.425
-2,936
5,212
Other working capital
-25,317
-25,317
-25,626
-8,957
-2,727
Other non-cash items
3,711
3,711
-32.208
-
-0.002
Net cash provided by operating activities
-25,119
-25,119
-23,460
1,987
10,005
Cash flows from investing activities
Investments in property, plant and equipment
-197.154
-197.154
-2,166
-10,944
-12,732
Net cash used for investing activities
-152.704
-152.704
-2,090
-10,944
-12,723
Cash flows from financing activities
Debt repayment
-1,156
-1,156
-2,421
-1,296
-1,579
Common stock issued
0
0
7,681
0
9,900
Common stock repurchased
0
0
-5,521
0
-
Other financing activities
-
-
34,340
34,340
-
Net cash used provided by (used for) financing activities
66,773
66,773
1,051
35,891
8,982
Net change in cash
41,519
41,519
-24,498
26,935
6,264
Cash at beginning of period
15,047
15,047
39,545
12,610
6,346
Cash at end of period
56,566
56,566
15,047
39,545
12,610
Free cash flow
Operating cash flow
-25,119
-25,119
-23,460
1,987
10,005
Capital expenditure
-197.154
-197.154
-2,166
-10,944
-12,732
Free cash flow
-25,317
-25,317
-25,626
-8,957
-2,727